Pharming Group (PHAR) said late Friday the European Commission has granted marketing authorization to Joenja for activated phosphoinositide 3-kinase delta syndrome, a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older.
Joenja is the first approved treatment in the European Union, the company said, expecting the first European launch in Germany in Q3 of 2026.
Price: $12.78, Change: $-0.03, Percent Change: -0.23%
Zoom Communications (ZM) reported fiscal Q1 adjusted diluted earnings late Thursday of $1.55 a share, up from $1.43 a year earlier.Analysts polled by FactSet expected $1.42.Revenue in the three months ended April 30 rose to $1.24 billion from $1.17 billion a year earlier.Analysts surveyed by FactSet expected $1.22 billion.The company expects fiscal Q2 non-GAAP diluted EPS of $1.45 to $1.47 on revenue of $1.265 billion to $1.27 billion. Analysts expect EPS of $1.49 on revenue of $1.266 billion.Zoom expects full-year non-GAAP diluted EPS of $5.96 to $6 on revenue of $5.08 billion to $5.09 billion, up from the prior outlook of EPS of $5.77 to $5.81 on revenue of $5.065 billion to $5.075 billion.Analysts polled by FactSet expect EPS of $5.88 on revenue of $5.075 billion.Zoom shares rose 7% in after-hours trading.
Deckers Outdoor (DECK) reported fiscal Q4 earnings late Thursday of $0.96 per diluted share, down from $1.00 a year earlier.Analysts polled by FactSet expected $0.83.Net sales for the quarter ended March 31 were $1.12 billion, up from $1.02 billion a year earlier.Analysts surveyed by FactSet expected $1.09 billion.The company expects fiscal 2027 earnings of $7.30 to $7.45 per share on net consolidated sales of $5.86 billion to $5.91 billion. Analysts polled by FactSet expect $7.35 and $5.82 billion, respectively.The company said its board has approved an increase of $3.5 billion to the stock repurchase authorization, which brings total outstanding authorization to about $5 billion.
Earnings Flash (TTWO) Take-Two Interactive Software Posts Fiscal Q4 Per Share Loss -$0.32, vs. FactSet Est of $-0.57 Loss